| # | Drug | Count |
|---|---|---|
| 0 | NICOTINE | 248 |
| 1 | BUPRENORPHINE | 70 |
| 2 | ESTRADIOL | 39 |
| 3 | FENTANYL | 22 |
| 4 | ROTIGOTINE | 20 |
| 5 | LEVOTHYROXINE SODIUM | 18 |
| 6 | NICOTINE POLACRILEX | 17 |
| 7 | ASPIRIN | 16 |
| 8 | GABAPENTIN | 16 |
| 9 | MINOXIDIL | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY | 1 | 0.2000 |
| 1 | BERDAZIMER | 3 | 0.0316 |
| 2 | ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY | 1 | 0.0278 |
| 3 | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0123 |
| 4 | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | 2 | 0.0065 |
| 5 | NICOTINE | 248 | 0.0061 |
| 6 | CLONIDINE TRANSDERMAL SYSTEM | 12 | 0.0056 |
| 7 | TAZAROTENE | 5 | 0.0042 |
| 8 | TESTOSTERONE GEL, 1% | 1 | 0.0039 |
| 9 | CLINDAMYCIN AND BENZOYL PEROXIDE | 1 | 0.0037 |
| # | Drug class | Count |
|---|---|---|
| 0 | Cholinergic Nicotinic Agonist [EPC] | 251 |
| 1 | Partial Opioid Agonist [EPC] | 70 |
| 2 | Estrogen [EPC] | 49 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 34 |
| 4 | Benzodiazepine [EPC] | 30 |
| 5 | Opioid Agonist [EPC] | 26 |
| 6 | Nonergot Dopamine Agonist [EPC] | 20 |
| 7 | Arteriolar Vasodilator [EPC] | 17 |
| 8 | Central alpha-2 Adrenergic Agonist [EPC] | 17 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cholinergic Nicotinic Agonist [EPC] | 251 | 0.0041 |
| 1 | Monoamine Oxidase Inhibitor [EPC] | 6 | 0.0019 |
| 2 | Nonergot Dopamine Agonist [EPC] | 20 | 0.0013 |
| 3 | Partial Opioid Agonist [EPC] | 70 | 0.0007 |
| 4 | Cholinesterase Inhibitor [EPC] | 12 | 0.0006 |
| 5 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 6 | Central alpha-2 Adrenergic Agonist [EPC] | 17 | 0.0003 |
| 7 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 8 | Estrogen [EPC] | 49 | 0.0003 |
| 9 | Anticholinergic [EPC] | 4 | 0.0002 |